Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $910.62 | 41 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $181.45 | 6 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $140.72 | 4 | $0 (2019) |
| Biohaven Pharmaceuticals, Inc. | $112.42 | 3 | $0 (2021) |
| Novo Nordisk Inc | $80.10 | 5 | $0 (2024) |
| Lilly USA, LLC | $60.69 | 4 | $0 (2024) |
| Medtronic, Inc. | $53.38 | 2 | $0 (2021) |
| PFIZER INC. | $50.55 | 3 | $0 (2024) |
| ABBVIE INC. | $48.06 | 3 | $0 (2024) |
| Corcept Therapeutics | $32.22 | 2 | $0 (2024) |
| Daiichi Sankyo Inc. | $27.14 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $475.56 | 23 | AstraZeneca Pharmaceuticals LP ($181.45) |
| 2023 | $28.83 | 2 | ABBVIE INC. ($16.00) |
| 2022 | $43.40 | 3 | Daiichi Sankyo Inc. ($27.14) |
| 2021 | $180.53 | 6 | Biohaven Pharmaceuticals, Inc. ($112.42) |
| 2020 | $41.58 | 3 | Lilly USA, LLC ($26.78) |
| 2019 | $140.72 | 4 | Sunovion Pharmaceuticals Inc. ($140.72) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/22/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Cardiology | ||||||
| 11/15/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $14.97 | General |
| Category: Endocrinology | ||||||
| 11/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.53 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.34 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Obesity | ||||||
| 10/01/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Endocrinology | ||||||
| 09/06/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $17.55 | General |
| Category: Psychology/Psychiatric | ||||||
| 06/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Diabetes | ||||||
| 05/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.42 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/08/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: VACCINES | ||||||
| 03/19/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $24.17 | General |
| Category: PSYCHIATRY | ||||||
| 03/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Diabetes | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $114.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes | ||||||
| 02/23/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $23.61 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 02/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: NEUROSCIENCE | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/02/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Diabetes | ||||||
| 01/17/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: VACCINES | ||||||
| 01/11/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/14/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/07/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 233 | 367 | $80,158 | $30,411 |
| 2022 | 9 | 263 | 366 | $78,034 | $29,356 |
| 2021 | 9 | 277 | 386 | $71,038 | $34,078 |
| 2020 | 4 | 217 | 387 | $78,445 | $31,791 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 64 | 171 | $49,436 | $17,577 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 37 | 37 | $10,786 | $5,086 | 47.2% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 34 | 35 | $6,580 | $2,763 | 42.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 23 | 23 | $4,672 | $1,711 | 36.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $4,136 | $1,276 | 30.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 20 | 45 | $2,700 | $1,213 | 44.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 30 | 30 | $1,322 | $599.40 | 45.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 14 | 15 | $526.00 | $186.00 | 35.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 135 | $39,420 | $14,039 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 38 | 38 | $11,324 | $5,392 | 47.6% |
| 99497 | Advance care planning, first 30 minutes | Office | 2022 | 45 | 45 | $8,460 | $3,494 | 41.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 22 | 26 | $10,556 | $3,266 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 17 | $3,502 | $1,008 | 28.8% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2022 | 21 | 35 | $2,100 | $981.98 | 46.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2022 | 30 | 30 | $1,290 | $611.07 | 47.4% |
| 99406 | Smoking and tobacco use intensive counseling, 4-10 minutes | Office | 2022 | 11 | 22 | $770.00 | $365.42 | 47.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 16 | 18 | $612.00 | $199.61 | 32.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 66 | 136 | $33,347 | $14,181 | 42.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 60 | 60 | $14,058 | $8,837 | 62.9% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 25 | 44 | $11,000 | $6,038 | 54.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 34 | $6,806 | $2,234 | 32.8% |
| 99497 | Advance care planning by the physician or other qualified health care professional, first 30 minutes | Office | 2021 | 12 | 12 | $2,280 | $1,066 | 46.8% |
| G0444 | Annual depression screening, 15 minutes | Office | 2021 | 42 | 42 | $1,695 | $888.30 | 52.4% |
| 99406 | Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes | Office | 2021 | 18 | 27 | $945.00 | $464.94 | 49.2% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2021 | 15 | 15 | $750.00 | $317.25 | 42.3% |
About Dr. Gary Oxenberg, MD
Dr. Gary Oxenberg, MD is a Family Medicine healthcare provider based in Northfield, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1346214533.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gary Oxenberg, MD has received a total of $910.62 in payments from pharmaceutical and medical device companies, with $475.56 received in 2024. These payments were reported across 41 transactions from 17 companies. The most common payment nature is "Food and Beverage" ($910.62).
As a Medicare-enrolled provider, Oxenberg has provided services to 990 Medicare beneficiaries, totaling 1,506 services with total Medicare billing of $125,636. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Other Specialties Internal Medicine
- Location Northfield, NJ
- Active Since 02/14/2006
- Last Updated 10/16/2025
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1346214533
Products in Payments
- FARXIGA (Drug) $181.45
- LONHALA MAGNAIR (Drug) $140.72
- NURTEC ODT (Drug) $112.42
- Ozempic (Drug) $64.26
- Minimed 770G System (Device) $42.22
- PREVNAR 20 (Biological) $35.21
- MOUNJARO (Drug) $33.91
- QULIPTA (Drug) $32.26
- Korlym (Drug) $32.22
- INJECTAFER (Drug) $27.14
- TRULICITY (Drug) $26.78
- REXULTI (Drug) $24.17
- HORIZANT (Drug) $23.61
- Auvelity (Drug) $17.55
- Repatha (Biological) $16.20
- Wegovy (Drug) $15.84
- VRAYLAR (Drug) $15.80
- ELIQUIS (Drug) $15.34
- JANUVIA (Drug) $14.80
- SOLIQUA 100/33 (Biological) $14.73
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Northfield
Arthur Nahas, D.o, D.O
Family Medicine — Payments: $16,460
Marlene Rodriguez, Md, MD
Family Medicine — Payments: $6,279
Dr. Seblewongel Bulcha Debosse, Md, MD
Family Medicine — Payments: $5,208
Dr. Stephen Bushay, Md, MD
Family Medicine — Payments: $2,639
Angel Reyes-Diaz, Md, MD
Family Medicine — Payments: $1,612
Dr. Donald Lum, Md, MD
Family Medicine — Payments: $130.00